Evecxia Therapeutics Strengthens Board of Directors With Appointments of Allan L. Shaw and Elliot Ehrich
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 30, 2023--
Stay updated with breaking news from Evecxia Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct 30, 2023--
Jacob Jacobsen, a co-founder of Evecxia Therapeutics along with the late Marc Caron and a former Duke University professor, is now the firm's chief executive officer.
Evecxia Therapeutics, a clinical-stage pharmaceutical company co-founded by two Duke neuro-psychopharmacologists, has secured $2.4M from Miami-based Collage Venture Partners.
Moncrieff et al. respond to the contradictory and, in some cases, false concerns raised by these critics of their serotonin review.
Academics and researchers in psychiatry and psychopharmacology criticize a review that questions the serotonin hypothesis of depression ― a bedrock principle of depression treatment.